JournalArta
Thursday, November 19, 2026 · JakartaS&P 7,323.63 ▼0.23%USD/IDR 18,263 ▲0.19%
JournalArta
Global Edition
beyond headlines
Advertisement

Gilead Sciences (GILD) Stock Update: Falls 0.75%, Up 10% in a Month

Technical analysis of GILD stock on November 18, 2026: price 168.98 USD, trend uptrend, RSI 59.1, support 156.04, resistance 174.48.

By matthew jonathan
November 19, 20265 min read
Gilead Sciences (GILD) Stock Update: Falls 0.75%, Up 10% in a Month
Logo Gilead Sciences — JournalArta illustration

Why GILD is in focus today

    Selected automatically from 11 NASDAQ (US) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.

    Gilead Sciences fell 0.75% to close at $168.98 on the Nasdaq on Wednesday, November 18, 2026, a modest pullback that still leaves the biopharmaceutical maker above its 20-day and 50-day moving averages. The stock slipped from a prior close of $170.26, and the move came on light volume — 4.96 million shares versus a 20-day average of 6.42 million, roughly 0.8 times normal — suggesting more drift than conviction. What separates this session from noise is context. Over the past month Gilead has gained 10.03%, though the five-day window shows a marginal 0.44% decline. The stock sits at 70% of its 20-day range, between support at $156.04 and resistance at $174.48, and below its three-month high of $176.58. This is a stock consolidating near the top of a recovery, not one breaking down.
    Advertisement

    Trend and Price Action

    The structural picture remains constructive. Gilead trades above its 20-day average of $166.30 and well above its 50-day average of $156.37. The 20-day average itself rose 2.03% over five trading days, a slope that signals the short-term trend is still pointing higher. No new moving-average cross formed in the latest session; the prevailing alignment — price above the shorter average, shorter average above the longer one — is the classic setup of an intact uptrend.
    Price action chart of GILD
    3-month price action chart of GILD: price, SMA20/50, Bollinger, support & resistance.
    Bollinger Bands, set at 20 periods and two standard deviations, place the upper band at $176.57, the middle at $166.30 and the lower at $156.03. The band width of 12.3% is normal, neither squeezed nor expanded, and the stock's 63% position within the bands (%B) shows it is in the upper-middle zone — not stretched to the ceiling, not sagging to the floor. The 20-day average and the middle band coincide, as they mathematically must, which sharpens the $166 region into a meaningful reference point.
    Advertisement

    Oscillators and Momentum

    Momentum is where the caution lies. The 14-day Relative Strength Index reads 59.1 — neutral, with room before overbought territory at 70. Stochastic, however, is softer: %K at 39.6 sits below %D at 51.9, a bearish crossover configuration that often precedes short-term weakness. MACD tells the same story: the line at 3.897 has slipped beneath its signal at 4.347, producing a negative histogram of -0.450.
    Momentum chart of GILD
    Momentum chart of GILD: RSI(14), MACD, Stochastic.
    The meaning matters more than the readings. A neutral RSI plus a negative MACD histogram and a stochastic rollover describe momentum cooling even as price holds up. That divergence — price near highs, momentum already turning — is typical of a pause or shallow pullback within a rising trend rather than a reversal. Crucially, none of these oscillators are oversold; RSI at 59.1 leaves plenty of headroom in either direction.
    Advertisement

    Volatility and Volume

    The Average True Range over 14 days is $5.24, or 3.1% of the last price, a moderate volatility reading. In practical terms, a normal day's swing is roughly five dollars, so a 0.75% decline is well inside routine movement. The thin volume accompanying the dip reinforces that reading: sellers were not aggressive. On-balance volume, though, is falling, meaning the cumulative flow of shares has leaned toward distribution over the recent stretch. That is the one participation signal that argues against the trend's strength.

    Key Levels and Scenarios

    Two levels frame the near term. On the upside, resistance rests at $174.48, with the three-month high of $176.58 just beyond; a decisive move through the resistance zone would confirm the uptrend and open the path suggested by the momentum reset. On the downside, the $166.30 area — where the SMA20 and Bollinger middle band converge — is the first test, followed by support at $156.04. If price slips below $166 and holds there, the trend's foundation begins to weaken; if it fails to hold $156, the uptrend is broken.
    Advertisement

    Fundamental Context

    The technical picture sits atop a business that is still growing. According to its SEC filing, Gilead reported quarterly revenue of $8.30 billion for the quarter ended September 30, 2026, up 6.8% from $7.77 billion a year earlier. Net income, however, fell to $2.43 billion from $3.05 billion, with diluted earnings per share of $1.94. Revenue growth paired with a lower profit line is the kind of mix that keeps investors watchful rather than euphoric. Put simply, the company is selling more but earning less per quarter — a detail that explains why a stock up more than 10% in a month can still stall.

    Technical Verdict: BUY

    The JournalArta research verdict is BUY, scored at +66 on a −100 to +100 scale, well above the +60 threshold. Three reasons anchor the call: - Price is above its 50-day average ($156.37), and the 20-day average ($166.30) is above the 50-day — a confirmed uptrend structure. - The 20-day average is rising 2.03% over five days, showing the trend is being sustained, not flattening. - RSI at 59.1 sits in the neutral 50–70 zone, leaving room for further gains without overbought conditions; the code's signal set shows one bullish trigger — a pullback to the SMA20 within an uptrend — against zero bearish triggers. The invalidation condition: the verdict is voided if price breaks below the stop at $160.07, which would undercut the trend's structure. - Entry range: $165.06 – $168.98 - Exit targets: $182.34 (target 1) and $195.71 (target 2) - Stop loss: $160.07 - Reward/risk: 1.5 / 3.0 - Valid until: December 17, 2026 Risks to respect: the MACD histogram is negative at -0.450 and OBV is falling — momentum and participation are not yet confirming the trend, which is why the entry range sits at or below the current price rather than above it. For a non-trader, the read is simple: Gilead's long-term direction is up and the recent dip looks like a pause, but the short-term momentum gauges say the next few weeks may be choppy — and the stop at $160.07 is the line where that story would change. *This is technical analysis, not investment advice. Data reflect the November 18, 2026 session.*
    Advertisement

    Summary Data GILD

    Last price168.98 USD
    Change 1 day / 5 days / 1 month-0.75% / -0.44% / 10.03%
    Trend / MA-crossuptrend / none
    SMA20 / SMA50166.30 / 156.37
    RSI (14) / Stochastic %K59.1 / 39.6
    Bollinger %B / ATR63% / 5.24
    Support / Resistance 20 days156.04 / 174.48
    Data as of19 November 2026 04:00 WIB
    JournalArta research verdict (score)Buy (+66)
    Entry zone165.06 – 168.98
    Target 1 / 2182.34 / 195.71
    Stop loss160.07
    Reward/risk1.5 / 3.0

    Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

    Advertisement
    Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
    Advertisement
    Most Read
    1. 1Gold Silver Price November: Futures Rise Near Yearly Lows
    2. 2U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage
    3. 3Michael Clarke Says Sandpapergate Scars Drew Steve Smith to New York
    4. 42027 NFL Mock Draft Puts Ohio State’s Jeremiah Smith at No. 1
    5. 5Brent Crude Slides 4.05% as Rising US Stockpiles Weigh on Oil
    Advertisement
    Don't Miss

    Latest News

    All stories →
    1. Markets · StocksBerkshire’s Kraft Heinz Stake Falls From $30 Billion to $8 BillionNov 19
    2. World · United StatesUS Army Plans Iowa Blast as Lead Dust Could Travel 100 MilesNov 19
    3. World · AustraliaVictoria Labor Scraps Andrews-Era Glass Bin MandateNov 19
    4. Sport · More SportsCameron Bancroft Says Whole Australia Team Knew of Ball TamperingNov 19
    5. Advertisement
    6. Lifestyle · Food & HealthTelehealth Consultations: How Doctors Can Improve CareNov 19
    7. Business · Companies2027 Nissan Patrol Starts at $98,990 in AustraliaNov 19
    8. Lifestyle · EntertainmentSally Hill’s Daughter Recounts Years of Abuse by Brian BehanNov 19
    9. Markets · StocksBerkshire Hathaway Stock Update: Slides 2.07%, Down 2.3% in Five SessionsNov 19